Pioglitazone
01/05/2018
/
By Zoey Sky
TOO TOXIC to swallow: Up to a third of diabetics don’t take their pills because of the debilitating side effects
According to a group of researchers, at least a third of diabetics do not take their medication due to fear of possible side effects. Diabetics in the U.K. are often prescribed metformin, the most commonly prescribed drug for type 2 diabetes. While there is no definite data on how many of the 3.4 million people in […]
08/01/2016
/
By diabetesscience
Pioglitazone decreases diabetes, stroke risks in patients with prediabetes, cerebrovascular disease
In insulin-resistant patients with a recent ischemic stroke or transient ischemic attack, pioglitazone was shown to reduce the risk for developing type 2 diabetes and major cardiovascular events, according to an analysis of the IRIS trial. (Article by healio.com) “Pioglitazone approximately halved the risk of developing diabetes in patients with insulin resistance and cerebrovascular disease,” […]
« Return Home
1 of 1
Popular Articles
COPYRIGHT © 2017 DIABETES SCIENCE NEWS
Privacy Policy